These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 2436331

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of pentosan polysulphate administration in man on the formation of covalent complexes between heparin cofactor II and thrombin generated in plasma by contact activation.
    Dol F, Sié P, Dupouy D, Boneu B.
    Thromb Haemost; 1986 Dec 15; 56(3):295-8. PubMed ID: 2436330
    [Abstract] [Full Text] [Related]

  • 3. Turnover study of heparin cofactor II in healthy man.
    Sié P, Dupouy D, Pichon J, Boneu B.
    Thromb Haemost; 1985 Oct 30; 54(3):635-8. PubMed ID: 3841420
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effect of sulfated xylans during the interaction of [125I]-thrombin with antithrombin III or heparin cofactor II of human plasma.
    Simmons RB, Newton GR, Doctor VM.
    Eur J Drug Metab Pharmacokinet; 1995 Oct 30; 20(1):73-7. PubMed ID: 7588997
    [Abstract] [Full Text] [Related]

  • 6. Respective role of antithrombin III and heparin cofactor II in the in vitro anticoagulant effect of heparin and of various sulphated polysaccharides.
    Sie P, Ofosu F, Fernandez F, Buchanan MR, Petitou M, Boneu B.
    Br J Haematol; 1986 Dec 30; 64(4):707-14. PubMed ID: 2432917
    [Abstract] [Full Text] [Related]

  • 7. Tolerance and biological activity of pentosan polysulfate after intramuscular or subcutaneous administration for ten days in human volunteers.
    Sié P, Albarede JL, Robert M, Bouloux C, Lansen J, Chigot C, Correll S, Thouvenot JP, Boneu B.
    Thromb Haemost; 1986 Feb 28; 55(1):86-9. PubMed ID: 2422778
    [Abstract] [Full Text] [Related]

  • 8. The effect of a sulfated polysaccharide on antithrombin III.
    Czapek EE, Kwaan HC, Szczecinski M.
    J Lab Clin Med; 1980 Jun 28; 95(6):783-90. PubMed ID: 6155418
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anticoagulant and antiheparin activities of a pentosan polysulphate.
    Scully MF, Weerasinghe KM, Ellis V, Djazaeri B, Kakkar VV.
    Thromb Res; 1983 Jul 01; 31(1):87-97. PubMed ID: 6193602
    [Abstract] [Full Text] [Related]

  • 11. A comparison of pentosan polysulphate and heparin. II: Effects of subcutaneous injection.
    Fischer AM, Merton RE, Marsh NA, Williams S, Gaffney PJ, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1982 Apr 30; 47(2):109-13. PubMed ID: 6179183
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pentosan polysulphate: activation of heparin cofactor II or antithrombin III according to molecular weight fractionation.
    Scully MF, Ellis V, Kakkar VV.
    Thromb Res; 1986 Feb 15; 41(4):489-99. PubMed ID: 2421433
    [Abstract] [Full Text] [Related]

  • 14. Identification of heparin cofactor II as the principal plasma cofactor for the antithrombin activity of pentosan polysulphate (SP54).
    Scully MF, Kakkar VV.
    Thromb Res; 1984 Oct 15; 36(2):187-94. PubMed ID: 6209821
    [Abstract] [Full Text] [Related]

  • 15. Phase I trial of orally administered pentosan polysulfate in patients with advanced cancer.
    Marshall JL, Wellstein A, Rae J, DeLap RJ, Phipps K, Hanfelt J, Yunmbam MK, Sun JX, Duchin KL, Hawkins MJ.
    Clin Cancer Res; 1997 Dec 15; 3(12 Pt 1):2347-54. PubMed ID: 9815633
    [Abstract] [Full Text] [Related]

  • 16. [The second cofactor of heparin].
    Sie P.
    Ann Biol Clin (Paris); 1987 Dec 15; 45(2):181-3. PubMed ID: 3619144
    [Abstract] [Full Text] [Related]

  • 17. Inhibition of thrombin-induced platelet aggregation and serotonin release by antithrombin III and heparin cofactor II in the presence of standard heparin, dermatan sulfate and pentosan polysulfate.
    Sié P, Fernandez F, Caranobe C, Gabaig AM, Boneu B.
    Thromb Res; 1984 Jul 15; 35(2):231-6. PubMed ID: 6206589
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of heparin cofactor II function by S protein (vitronectin) and formation of a ternary S protein-thrombin-heparin cofactor II complex.
    Preissner KT, Sié P.
    Thromb Haemost; 1988 Dec 22; 60(3):399-406. PubMed ID: 2976993
    [Abstract] [Full Text] [Related]

  • 19. Antithrombin III and heparin cofactor II in patients with chronic renal failure undergoing regular hemodialysis.
    Toulon P, Jacquot C, Capron L, Frydman MO, Vignon D, Aiach M.
    Thromb Haemost; 1987 Jun 03; 57(3):263-8. PubMed ID: 3660328
    [Abstract] [Full Text] [Related]

  • 20. Homozygous variant of antithrombin III that lacks affinity for heparin, AT III Kumamoto.
    Okajima K, Ueyama H, Hashimoto Y, Sasaki Y, Matsumoto K, Okabe H, Inoue M, Araki S, Takatsuki K.
    Thromb Haemost; 1989 Feb 28; 61(1):20-4. PubMed ID: 2749590
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.